Terns Pharmaceuticals, Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Terns Pharmaceuticals, Inc. reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $3.71 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-03-30
- Terns Pharmaceuticals, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $3.71M, a 148.86% increase from fiscal 2024.
- Terns Pharmaceuticals, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $1.49M, a 11.28% increase from fiscal 2023.
- Terns Pharmaceuticals, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $1.34M, a 89.66% increase from fiscal 2022.
- Terns Pharmaceuticals, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $706.00K, a 56.54% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $3.71M 10-K · filed 2026-03-30 |
| 2024-12-31 | $1.49M 10-K · filed 2026-03-30 |
| 2023-12-31 | $1.34M 10-K · filed 2025-03-20 |
| 2022-12-31 | $706.00K 10-K · filed 2024-03-14 |
| 2021-12-31 | $451.00K 10-K · filed 2023-03-27 |
| 2020-12-31 | $697.00K 10-K · filed 2022-03-07 |